293 related articles for article (PubMed ID: 30477560)
1. Phase II trial on SBRT for unresectable liver metastases: long-term outcome and prognostic factors of survival after 5 years of follow-up.
Scorsetti M; Comito T; Clerici E; Franzese C; Tozzi A; Iftode C; Di Brina L; Navarria P; Mancosu P; Reggiori G; Fogliata A; Tomatis S; Torzilli G; Cozzi L
Radiat Oncol; 2018 Nov; 13(1):234. PubMed ID: 30477560
[TBL] [Abstract][Full Text] [Related]
2. Role of stereotactic body radiation therapy in the treatment of liver metastases: clinical results and prognostic factors.
Clerici E; Comito T; Franzese C; Di Brina L; Tozzi A; Iftode C; Navarria P; Mancosu P; Reggiori G; Tomatis S; Scorsetti M
Strahlenther Onkol; 2020 Apr; 196(4):325-333. PubMed ID: 31605163
[TBL] [Abstract][Full Text] [Related]
3. Additional chemotherapy improved local control and overall survival after stereotactic body radiation therapy for patients with oligo-recurrence.
Nakamura M; Hashimoto N; Mayahara H; Uezono H; Harada A; Nishikawa R; Matsuo Y; Kawaguchi H; Nishimura H
Radiat Oncol; 2018 Apr; 13(1):75. PubMed ID: 29688858
[TBL] [Abstract][Full Text] [Related]
4. Is stereotactic body radiation therapy an attractive option for unresectable liver metastases? A preliminary report from a phase 2 trial.
Scorsetti M; Arcangeli S; Tozzi A; Comito T; Alongi F; Navarria P; Mancosu P; Reggiori G; Fogliata A; Torzilli G; Tomatis S; Cozzi L
Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):336-42. PubMed ID: 23433800
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome of Stereotactic Body Radiation Therapy for patient with unresectable liver metastases from colorectal cancer.
Py JF; Salleron J; Courrech F; Beckendorf V; Croisé-Laurent V; Peiffert D; Vogin G; Dietmann AS
Cancer Radiother; 2021 Jun; 25(4):350-357. PubMed ID: 33618909
[TBL] [Abstract][Full Text] [Related]
6. The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases.
Andratschke N; Alheid H; Allgäuer M; Becker G; Blanck O; Boda-Heggemann J; Brunner T; Duma M; Gerum S; Guckenberger M; Hildebrandt G; Klement RJ; Lewitzki V; Ostheimer C; Papachristofilou A; Petersen C; Schneider T; Semrau R; Wachter S; Habermehl D
BMC Cancer; 2018 Mar; 18(1):283. PubMed ID: 29534687
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic Body Radiotherapy (SBRT) for liver metastasis - clinical outcomes from the international multi-institutional RSSearch® Patient Registry.
Mahadevan A; Blanck O; Lanciano R; Peddada A; Sundararaman S; D'Ambrosio D; Sharma S; Perry D; Kolker J; Davis J
Radiat Oncol; 2018 Feb; 13(1):26. PubMed ID: 29439707
[TBL] [Abstract][Full Text] [Related]
8. A single-institution study of stereotactic body radiotherapy for patients with unresectable visceral pulmonary or hepatic oligometastases.
Fumagalli I; Bibault JE; Dewas S; Kramar A; Mirabel X; Prevost B; Lacornerie T; Jerraya H; Lartigau E
Radiat Oncol; 2012 Sep; 7():164. PubMed ID: 23014094
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic Body Radiotherapy (SBRT) for Spinal Metastases: Who Will Benefit the Most from SBRT?
Park HJ; Kim HJ; Won JH; Lee SC; Chang AR
Technol Cancer Res Treat; 2015 Apr; 14(2):159-67. PubMed ID: 24502552
[TBL] [Abstract][Full Text] [Related]
10. The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT).
Scorsetti M; Comito T; Cozzi L; Clerici E; Tozzi A; Franzese C; Navarria P; Fogliata A; Tomatis S; D'Agostino G; Iftode C; Mancosu P; Ceriani R; Torzilli G
J Cancer Res Clin Oncol; 2015 Jul; 141(7):1301-9. PubMed ID: 25644863
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic body radiation therapy: A promising chance for oligometastatic breast cancer.
Scorsetti M; Franceschini D; De Rose F; Comito T; Villa E; Iftode C; Navarria P; D'Agostino GR; Masci G; Torrisi R; Testori A; Tinterri C; Santoro A
Breast; 2016 Apr; 26():11-7. PubMed ID: 27017237
[TBL] [Abstract][Full Text] [Related]
12. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases.
Rusthoven KE; Kavanagh BD; Cardenes H; Stieber VW; Burri SH; Feigenberg SJ; Chidel MA; Pugh TJ; Franklin W; Kane M; Gaspar LE; Schefter TE
J Clin Oncol; 2009 Apr; 27(10):1572-8. PubMed ID: 19255321
[TBL] [Abstract][Full Text] [Related]
13. Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study.
Milano MT; Katz AW; Zhang H; Okunieff P
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):878-86. PubMed ID: 22172903
[TBL] [Abstract][Full Text] [Related]
14. Clinical results of mean GTV dose optimized robotic guided SBRT for liver metastases.
Andratschke N; Parys A; Stadtfeld S; Wurster S; Huttenlocher S; Imhoff D; Yildirim M; Rades D; Rödel CM; Dunst J; Hildebrandt G; Blanck O
Radiat Oncol; 2016 May; 11():74. PubMed ID: 27236333
[TBL] [Abstract][Full Text] [Related]
15. Final results of a phase II trial for stereotactic body radiation therapy for patients with inoperable liver metastases from colorectal cancer.
Scorsetti M; Comito T; Tozzi A; Navarria P; Fogliata A; Clerici E; Mancosu P; Reggiori G; Rimassa L; Torzilli G; Tomatis S; Santoro A; Cozzi L
J Cancer Res Clin Oncol; 2015 Mar; 141(3):543-53. PubMed ID: 25245052
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy".
Rieber J; Streblow J; Uhlmann L; Flentje M; Duma M; Ernst I; Blanck O; Wittig A; Boda-Heggemann J; Krempien R; Lohaus F; Klass ND; Eble MJ; Imhoff D; Kahl H; Petersen C; Gerum S; Henkenberens C; Adebahr S; Hass P; Schrade E; Wendt TG; Hildebrandt G; Andratschke N; Sterzing F; Guckenberger M
Lung Cancer; 2016 Jul; 97():51-8. PubMed ID: 27237028
[TBL] [Abstract][Full Text] [Related]
17. Short-term outcomes and clinical efficacy of stereotactic body radiation therapy (SBRT) in treatment of adrenal gland metastases from lung cancer.
Zhao X; Zhu X; Fei J; Ren H; Cao Y; Ju X; Yuan Z; Zhang H
Radiat Oncol; 2018 Oct; 13(1):205. PubMed ID: 30348187
[TBL] [Abstract][Full Text] [Related]
18. Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cm.
Su TS; Lu HZ; Cheng T; Zhou Y; Huang Y; Gao YC; Tang MY; Jiang HY; Lian ZP; Hou EC; Liang P
BMC Cancer; 2016 Nov; 16(1):834. PubMed ID: 27809890
[TBL] [Abstract][Full Text] [Related]
19. Treatment outcomes of breast cancer liver metastasis treated with stereotactic body radiotherapy.
Onal C; Guler OC; Yildirim BA
Breast; 2018 Dec; 42():150-156. PubMed ID: 30296648
[TBL] [Abstract][Full Text] [Related]
20. Lung Metastases Treated With Stereotactic Ablative Radiation Therapy in Oligometastatic Colorectal Cancer Patients: Outcomes and Prognostic Factors After Long-Term Follow-Up.
Agolli L; Bracci S; Nicosia L; Valeriani M; De Sanctis V; Osti MF
Clin Colorectal Cancer; 2017 Mar; 16(1):58-64. PubMed ID: 27522627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]